Cathepsin K regulates localization and secretion of Tartrate-Resistant Acid Phosphatase (TRAP) in TRAP-overexpressing MDA-MB-231 breast cancer cells
Open Access
- 18 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Molecular and Cell Biology
- Vol. 21 (1), 1-15
- https://doi.org/10.1186/s12860-020-00253-6
Abstract
Tartrate–resistant acid phosphatase (TRAP/ ACP5) belongs to the binuclear metallophosphatase family and is present in two isoforms. The primary translation product is an uncleaved TRAP 5a isoform with low phosphatase activity. TRAP 5a can be post-translationally processed to a cleaved TRAP 5b isoform with high phosphatase activity by e.g. cysteine proteinases, such as Cathepsin K (CtsK). The relevance of the phosphatase activity of TRAP 5b has been demonstrated for proliferation, migration and invasion of cancer cells. TRAP-overexpressing MDA-MB-231 breast cancer cells displayed higher levels of TRAP 5a and efficient processing of TRAP 5a to TRAP 5b protein, but no changes in levels of CtsK when compared to mock-transfected cells. In TRAP-overexpressing cells colocalization of TRAP 5a and proCtsK was augmented, providing a plausible mechanism for generation of TRAP 5b. CtsK expression has been associated with cancer progression and has been pharmacologically targeted in several clinical studies. In the current study, CtsK inhibition with MK-0822/Odanacatib did not abrogate the formation of TRAP 5b, but reversibly increased the intracellular levels of a N-terminal fragment of TRAP 5b and reduced secretion of TRAP 5a reversibly. However, MK-0822 treatment neither altered intracellular TRAP activity nor TRAP-dependent cell migration, suggesting involvement of additional proteases in proteolytic processing of TRAP 5a. Notwithstanding, CtsK was shown to be colocalized with TRAP and to be involved in the regulation of secretion of TRAP 5a in a breast cancer cell line, while it still was not essential for processing of TRAP 5a to TRAP 5b isoform. In cancer cells multiple proteases are involved in cleaving TRAP 5a to high-activity phosphatase TRAP 5b. However, CtsK-inhibiting treatment was able to reduce secretion TRAP 5a from TRAP-overexpressing cancer cells.Keywords
Funding Information
- Vetenskapsrådet (#2017-01083, K2015-99X-10363-23-4)
- Cancerfonden (2016)
- Cancer and Allergy Foundation (2017)
- Jane ja Aatos Erkon Säätiö (2017)
- Loo och Hans Ostermans Stiftelse för Medicinsk Forskning (2018)
- Maud Kuistilan Muistosäätiö (2017)
This publication has 54 references indexed in Scilit:
- Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formationJCI Insight, 2013
- The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular traffickingBone, 2011
- Multiplex Zymography Captures Stage-specific Activity Profiles of Cathepsins K, L, and S in Human Breast, Lung, and Cervical CancerJournal of Translational Medicine, 2011
- Proinvasion Metastasis Drivers in Early-Stage Melanoma Are OncogenesCancer Cell, 2011
- Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor ProgressionClinical Cancer Research, 2008
- Crystal Structures of Recombinant Human Purple Acid Phosphatase With and Without an Inhibitory Conformation of the Repression LoopJournal of Molecular Biology, 2005
- Substrate positioning by His92 is important in catalysis by purple acid phosphataseThe FEBS Journal, 2005
- TRACP as an Osteopontin PhosphataseJournal of Bone and Mineral Research, 2003
- Tartrate‐resistant acid phosphatase isoform 5b: A novel serum marker for monitoring bone disease in multiple myelomaInternational Journal of Cancer, 2003
- Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human OsteoclastsPublished by Elsevier BV ,1996